Next Phase: Global Funding Insights for Digital Health Initiatives in 2018

Newsletter | July 12, 2018 | Issue 274

The LSN Story

Investor Platform

Company Platform

RESI Conference

LSN Consulting

Hot Investor Mandates

Singapore-Based PE Firm

Invests Up to $20M in All Areas of Life Sciences with Potential for Global Growth, Open to Any Stage of Development

Hong Kong PE Firm

Seeks to Invest Up to $10 M in Clinically Validated Medical Device and Diagnostics Products with China Angle

Venture Capital Firm

Seeks to Invest in Medical Device, Scientific Instrument, and Digital Health Technologies in the Midwest and Southern California

Newly Established VC Fund

Invests in Innovative Digital Health and Medtech/Diagnostics Technologies with Software Components

Top-tier early-stage companies in life sciences from around the globe are invited to apply for the Innovation Challenge!

Apply

Global Funding Insights for Digital Health Initiatives in 2018

By Ashley Durrer, Marketing Manager, LSN

This week I interviewed Colin Widen, the CEO of Boston Innovation Capital (BIC) , Life Science Nation’s (LSN) wholly-owned broker-dealer arm, to learn where investors are allocating funds, and the current focus on healthcare advancement within the digital health space.

BIC works alongside LSN and our network of investors to support early-stage companies in forging connections with investors, major pharma firms, and other strategic players in the life science world. By managing clients’ fundraising campaigns and connecting them to investors who are a good fit, BIC is able to address its, and LSN’s, mission of advancing new and innovative technologies to the clinic.

Interview with Colin Widen moderated by Ashley Durrer

AD: Where does BIC fit into global funding from client perspectives?

CW: “BIC is working tirelessly to support digital health technologies that will have a real impact on the healthcare system for our doctors, nurses, and hospitals. This year BIC is focused on digital health technologies, assets, and virtual tools, which can support doctors’, hospitals’, and nurses’ efforts with patients. However, this currently excludes consumer-based products and electronic medical record (EMR) initiatives.”

AD: What are some examples of potential best-fit clients?

CW: “Some examples recognized in the market are pill dispensers and medicinal tracking for patient compliance, health portals for patients and doctors, mental health apps, medication tracking, patient monitoring and more.”

AD: What kind of client are you seeking now? Can you share a potential client profile?

CW: “Within our LSN network of investors, feedback clearly shows there is an increasing appetite to invest in niche digital health opportunities.

“Investors are seeking companies within the top-tier of their specialization, and a proven business model within the market. Often these investors want to see that the product, software, tool, etc. are viable, which means it’s already being used within the market e.g. hospitals. This also includes an accompanying value proposition for payors and the company is receiving ongoing revenue for that service.”

BIC Global Network of Digital Health Investors are focused on:

Funding of $10M-50M
Min $3mm+ ARR
Niche companies within the top-tier of their specialization
Currently avoiding pure EMR focused and consumer-based products

RESI Healthtech Week Attendee Breakdown

The inaugural RESI Healthtech Week (RHW) launches on September 5th at the Boston Marriott Copley Place with a new conference – the First Coast Innovators Gathering!

Visit our website

Ask About Our 2 Days for the Price of One Exhibitor Deal

RESI Sponsorships

Participate and gain unprecedented visibility into the early stage life science community and leverage our close-knit network of key decision makers to make promising connections with future clients and strategic partners.

More info about RESI Sponsorship, please reply to this email or contact:

RESI Team

Direct: 617-600-0668

Email: resi@lifesciencenation.com

RESI Exhibitor Package

RESI is looking for service providers and regional life science organizations to participate in the conference as an exhibitor where your company will gain visibility and engage with future customers.

Click here to check more info about exhibitor opportunities or contact:

Bryanna Allison

Business Development Manager

RESI Conference Series

Direct: (617) 580-5011

Email: b.allison@lifesciencenation.com

LSN Summer Reading Series

Chapter 3

Going It Alone or Choosing a Fundraising Partner

With the third installment of the summer reading series we take a look at the important decision of whether or not one should use a fundraising partner to help them in securing capital. Chapter 3 of The Life Science Executive’s Fundraising Manifesto “ Going It Alone or Choosing a Fundraising Partner ,” tackles this question head-on, describing what companies would be a suitable fit for fundraising partners, providing a breakdown of the different types in the marketplace today, and advising readers on how to go about vetting a potential partner.

Click here to download/print the PDF.

We hope you enjoy this chapter. Next week, join us for “ Chapter 4: Categories of Life Science Investors. ”

Click here to download chapter 3

The Life Science Executive’s Fundraising Manifesto helps scientists understand the fundamental skills needed to brand and market their companies. It discusses how to use a consistent message to achieve compelling results from a fundraising campaign and how to aggregate a list of potential global investors that are a fit for your company’s products and services.